

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.15384987 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.15384987 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.13017225 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.03021833 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.03021833 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.03021833 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.03021833 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.03021833 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 6.03021833 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.65130233 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.57736840 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.36745134 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 5.20638684 |
| 14 | detection of other organism (GO:0098543) | 5.13953544 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.12352319 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 5.10054091 |
| 17 | detection of molecule of bacterial origin (GO:0032490) | 4.97842586 |
| 18 | response to peptidoglycan (GO:0032494) | 4.93356674 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 4.86608740 |
| 20 | detection of bacterium (GO:0016045) | 4.80086388 |
| 21 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.72808802 |
| 22 | cellular response to type I interferon (GO:0071357) | 4.68168663 |
| 23 | type I interferon signaling pathway (GO:0060337) | 4.68168663 |
| 24 | response to type I interferon (GO:0034340) | 4.64833840 |
| 25 | detection of external biotic stimulus (GO:0098581) | 4.61643216 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.45522922 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.44567807 |
| 28 | microglial cell activation (GO:0001774) | 4.40312185 |
| 29 | cellular extravasation (GO:0045123) | 4.40186695 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 4.27706445 |
| 31 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.26003532 |
| 32 | response to host immune response (GO:0052572) | 4.22999414 |
| 33 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.22999414 |
| 34 | neutrophil activation (GO:0042119) | 4.22481835 |
| 35 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.19516201 |
| 36 | leukocyte aggregation (GO:0070486) | 4.15275071 |
| 37 | detection of biotic stimulus (GO:0009595) | 4.12865641 |
| 38 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.11527863 |
| 39 | regulation of gamma-delta T cell activation (GO:0046643) | 4.07253774 |
| 40 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.01801737 |
| 41 | negative regulation of T cell mediated immunity (GO:0002710) | 4.00016747 |
| 42 | regulation of T cell tolerance induction (GO:0002664) | 3.97281464 |
| 43 | respiratory burst (GO:0045730) | 3.96851123 |
| 44 | macrophage activation (GO:0042116) | 3.86655415 |
| 45 | response to interleukin-15 (GO:0070672) | 3.84527000 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.83587152 |
| 47 | response to host (GO:0075136) | 3.83587152 |
| 48 | response to host defenses (GO:0052200) | 3.83587152 |
| 49 | regulation of tolerance induction (GO:0002643) | 3.83441053 |
| 50 | granulocyte activation (GO:0036230) | 3.83030703 |
| 51 | response to interferon-alpha (GO:0035455) | 3.82798770 |
| 52 | neutrophil mediated immunity (GO:0002446) | 3.79384529 |
| 53 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.77065114 |
| 54 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.74744264 |
| 55 | myeloid cell activation involved in immune response (GO:0002275) | 3.67581919 |
| 56 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.65555077 |
| 57 | positive regulation of type 2 immune response (GO:0002830) | 3.65190548 |
| 58 | cellular response to interleukin-15 (GO:0071350) | 3.56835052 |
| 59 | positive regulation of interferon-alpha production (GO:0032727) | 3.54199500 |
| 60 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.48750208 |
| 61 | myeloid leukocyte mediated immunity (GO:0002444) | 3.46506578 |
| 62 | T cell migration (GO:0072678) | 3.44591405 |
| 63 | B cell mediated immunity (GO:0019724) | 3.43193106 |
| 64 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.40650773 |
| 65 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.40293025 |
| 66 | regulation of mast cell degranulation (GO:0043304) | 3.39411546 |
| 67 | regulation of interferon-alpha production (GO:0032647) | 3.37666798 |
| 68 | positive regulation of tolerance induction (GO:0002645) | 3.35879537 |
| 69 | positive regulation of mast cell activation (GO:0033005) | 3.34022799 |
| 70 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.33348921 |
| 71 | defense response to protozoan (GO:0042832) | 3.32478083 |
| 72 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.30541356 |
| 73 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.30254920 |
| 74 | dendritic cell chemotaxis (GO:0002407) | 3.26492286 |
| 75 | regulation of mast cell activation (GO:0033003) | 3.25062179 |
| 76 | dendritic cell migration (GO:0036336) | 3.22430541 |
| 77 | response to interferon-beta (GO:0035456) | 3.20350074 |
| 78 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.20116398 |
| 79 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.19472417 |
| 80 | regulation of type 2 immune response (GO:0002828) | 3.18673557 |
| 81 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.17586230 |
| 82 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.14891468 |
| 83 | regulation of regulatory T cell differentiation (GO:0045589) | 3.14728094 |
| 84 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.14714614 |
| 85 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.14487641 |
| 86 | regulation of antigen processing and presentation (GO:0002577) | 3.13916396 |
| 87 | negative regulation of innate immune response (GO:0045824) | 3.11460926 |
| 88 | positive regulation of antigen processing and presentation (GO:0002579) | 3.10429744 |
| 89 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.08988353 |
| 90 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.07698963 |
| 91 | germinal center formation (GO:0002467) | 3.05363887 |
| 92 | leukocyte degranulation (GO:0043299) | 3.05050900 |
| 93 | negative regulation of type 2 immune response (GO:0002829) | 3.03214792 |
| 94 | lymphocyte chemotaxis (GO:0048247) | 3.02641017 |
| 95 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.00710128 |
| 96 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.00023224 |
| 97 | response to muramyl dipeptide (GO:0032495) | 2.99977554 |
| 98 | positive regulation of interferon-beta production (GO:0032728) | 2.99484397 |
| 99 | B cell receptor signaling pathway (GO:0050853) | 2.96570382 |
| 100 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.95727034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.19455268 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.02001143 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.94859400 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.30110863 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.91678826 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.74746988 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.63381159 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.62758121 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.50830839 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.19911256 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.74641686 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.70808062 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.70197886 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.68482406 |
| 15 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.68186068 |
| 16 | SPI1_23127762_ChIP-Seq_K562_Human | 2.45108964 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.44016330 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.42702486 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.35072311 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.34168318 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.32230790 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30482519 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.14326816 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.07212913 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.04042152 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.03890857 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.03580983 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 2.02481877 |
| 29 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.01852100 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.01736627 |
| 31 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.93667550 |
| 32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.92858757 |
| 33 | MYB_26560356_Chip-Seq_TH1_Human | 1.90926098 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88831552 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.81344272 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.79935722 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79419072 |
| 38 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.75295516 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70934941 |
| 40 | GATA3_26560356_Chip-Seq_TH2_Human | 1.63974956 |
| 41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62917220 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62802289 |
| 43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57452902 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.50866215 |
| 45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44076740 |
| 46 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.43813901 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43719910 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.39420302 |
| 49 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38909034 |
| 50 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38566597 |
| 51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37707658 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35081327 |
| 53 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30656137 |
| 54 | MYC_22102868_ChIP-Seq_BL_Human | 1.29985627 |
| 55 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.28988709 |
| 56 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28147748 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.26451215 |
| 58 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.26270793 |
| 59 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26062146 |
| 60 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25350684 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25074523 |
| 62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24859507 |
| 63 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.22886551 |
| 64 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21432863 |
| 65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19755209 |
| 66 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16142519 |
| 67 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14574831 |
| 68 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.10619010 |
| 69 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10549441 |
| 70 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08259995 |
| 71 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07900184 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05410740 |
| 73 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05143930 |
| 74 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04846509 |
| 75 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04792416 |
| 76 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.03473919 |
| 77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03423501 |
| 78 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03091397 |
| 79 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.01296322 |
| 80 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00484560 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98302437 |
| 82 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95910288 |
| 83 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95876938 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92146295 |
| 85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91327399 |
| 86 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89528295 |
| 87 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.84898928 |
| 88 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.84835000 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82386244 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82064017 |
| 91 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.80543047 |
| 92 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80488356 |
| 93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.79825232 |
| 94 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.78075108 |
| 95 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.77432106 |
| 96 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.75896204 |
| 97 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.74805172 |
| 98 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73009221 |
| 99 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.70574141 |
| 100 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70470165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.82101339 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.20042095 |
| 3 | MP0003436_decreased_susceptibility_to | 4.03516795 |
| 4 | MP0003303_peritoneal_inflammation | 3.82021880 |
| 5 | MP0009785_altered_susceptibility_to | 3.39237742 |
| 6 | MP0002419_abnormal_innate_immunity | 3.22030410 |
| 7 | MP0005671_abnormal_response_to | 3.20218196 |
| 8 | MP0006082_CNS_inflammation | 3.16171704 |
| 9 | MP0005025_abnormal_response_to | 3.09635553 |
| 10 | MP0001800_abnormal_humoral_immune | 3.06071543 |
| 11 | MP0000685_abnormal_immune_system | 3.03064077 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.97660907 |
| 13 | MP0001790_abnormal_immune_system | 2.93137484 |
| 14 | MP0005387_immune_system_phenotype | 2.93137484 |
| 15 | MP0002723_abnormal_immune_serum | 2.75581950 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.68020100 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.64345276 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.55384216 |
| 19 | MP0001819_abnormal_immune_cell | 2.54333091 |
| 20 | MP0001533_abnormal_skeleton_physiology | 2.16946869 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.06122130 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.96504949 |
| 23 | MP0002405_respiratory_system_inflammati | 1.96462398 |
| 24 | MP0002277_abnormal_respiratory_mucosa | 1.91414106 |
| 25 | MP0000716_abnormal_immune_system | 1.88362924 |
| 26 | MP0001845_abnormal_inflammatory_respons | 1.88075262 |
| 27 | MP0002132_abnormal_respiratory_system | 1.87902004 |
| 28 | MP0009764_decreased_sensitivity_to | 1.87467349 |
| 29 | MP0008260_abnormal_autophagy | 1.83096153 |
| 30 | MP0002398_abnormal_bone_marrow | 1.82694033 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.80287358 |
| 32 | MP0003763_abnormal_thymus_physiology | 1.79715519 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.77785756 |
| 34 | MP0004947_skin_inflammation | 1.64110671 |
| 35 | MP0003828_pulmonary_edema | 1.63817205 |
| 36 | MP0008469_abnormal_protein_level | 1.61886202 |
| 37 | MP0009278_abnormal_bone_marrow | 1.59121491 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.56881511 |
| 39 | MP0003866_abnormal_defecation | 1.51013775 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.48231057 |
| 41 | MP0002722_abnormal_immune_system | 1.46336026 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.45936264 |
| 43 | MP0002429_abnormal_blood_cell | 1.45702098 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.43237253 |
| 45 | MP0005310_abnormal_salivary_gland | 1.36942927 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.34198478 |
| 47 | MP0004883_abnormal_blood_vessel | 1.32605126 |
| 48 | MP0003075_altered_response_to | 1.30267797 |
| 49 | MP0004510_myositis | 1.27640696 |
| 50 | MP0005451_abnormal_body_composition | 1.25070863 |
| 51 | MP0000703_abnormal_thymus_morphology | 1.23491473 |
| 52 | MP0000858_altered_metastatic_potential | 1.21338600 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.20804913 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.20804913 |
| 55 | MP0002396_abnormal_hematopoietic_system | 1.20118330 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.18314080 |
| 57 | MP0004381_abnormal_hair_follicle | 1.17244120 |
| 58 | MP0005164_abnormal_response_to | 1.13351880 |
| 59 | MP0003690_abnormal_glial_cell | 1.11830339 |
| 60 | MP0003806_abnormal_nucleotide_metabolis | 1.11455825 |
| 61 | MP0001851_eye_inflammation | 1.10569738 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.07149959 |
| 63 | MP0000343_altered_response_to | 1.03897260 |
| 64 | MP0000569_abnormal_digit_pigmentation | 1.00684591 |
| 65 | MP0005166_decreased_susceptibility_to | 0.98660104 |
| 66 | MP0003448_altered_tumor_morphology | 0.98624290 |
| 67 | MP0009763_increased_sensitivity_to | 0.93507561 |
| 68 | MP0001663_abnormal_digestive_system | 0.87288241 |
| 69 | MP0003045_fibrosis | 0.87071592 |
| 70 | MP0002006_tumorigenesis | 0.85185726 |
| 71 | MP0005390_skeleton_phenotype | 0.81691374 |
| 72 | MP0008004_abnormal_stomach_pH | 0.80692914 |
| 73 | MP0002332_abnormal_exercise_endurance | 0.79817990 |
| 74 | MP0009765_abnormal_xenobiotic_induced | 0.77188211 |
| 75 | MP0001853_heart_inflammation | 0.75554995 |
| 76 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74794462 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 0.74508772 |
| 78 | MP0001873_stomach_inflammation | 0.72774875 |
| 79 | MP0001986_abnormal_taste_sensitivity | 0.70641540 |
| 80 | MP0000604_amyloidosis | 0.67998896 |
| 81 | MP0002138_abnormal_hepatobiliary_system | 0.66821710 |
| 82 | MP0004808_abnormal_hematopoietic_stem | 0.66535058 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.64615567 |
| 84 | MP0008874_decreased_physiological_sensi | 0.61777456 |
| 85 | MP0005075_abnormal_melanosome_morpholog | 0.60765526 |
| 86 | MP0000015_abnormal_ear_pigmentation | 0.60660114 |
| 87 | MP0002693_abnormal_pancreas_physiology | 0.58831629 |
| 88 | MP0000249_abnormal_blood_vessel | 0.58372856 |
| 89 | MP0003787_abnormal_imprinting | 0.57648422 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 0.56469505 |
| 91 | MP0003795_abnormal_bone_structure | 0.56004149 |
| 92 | MP0004130_abnormal_muscle_cell | 0.55597753 |
| 93 | MP0005058_abnormal_lysosome_morphology | 0.55127555 |
| 94 | MP0000490_abnormal_crypts_of | 0.53778349 |
| 95 | MP0003878_abnormal_ear_physiology | 0.53244017 |
| 96 | MP0005377_hearing/vestibular/ear_phenot | 0.53244017 |
| 97 | MP0002933_joint_inflammation | 0.51797613 |
| 98 | MP0004484_altered_response_of | 0.51381215 |
| 99 | MP0000920_abnormal_myelination | 0.50433751 |
| 100 | MP0005376_homeostasis/metabolism_phenot | 0.48484533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.64351925 |
| 2 | Myositis (HP:0100614) | 6.41557673 |
| 3 | Orchitis (HP:0100796) | 6.38879181 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.28995808 |
| 5 | Optic neuritis (HP:0100653) | 6.26953219 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 6.26953219 |
| 7 | Recurrent abscess formation (HP:0002722) | 6.16511258 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.53908735 |
| 9 | Stomatitis (HP:0010280) | 5.38212447 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.19438109 |
| 11 | Gastrointestinal infarctions (HP:0005244) | 5.05084195 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.89955694 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.48115976 |
| 14 | Keratoconjunctivitis sicca (HP:0001097) | 4.47747274 |
| 15 | Recurrent skin infections (HP:0001581) | 4.29764930 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 4.24014172 |
| 17 | Keratoconjunctivitis (HP:0001096) | 4.21245062 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 4.15477944 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.15477944 |
| 20 | Hypochromic microcytic anemia (HP:0004840) | 4.14418992 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.10389563 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 4.06781720 |
| 23 | Obstructive lung disease (HP:0006536) | 4.06781720 |
| 24 | Encephalitis (HP:0002383) | 4.04124549 |
| 25 | Meningitis (HP:0001287) | 4.00848531 |
| 26 | Vasculitis (HP:0002633) | 3.75877891 |
| 27 | Hemoptysis (HP:0002105) | 3.62033327 |
| 28 | Urticaria (HP:0001025) | 3.58800439 |
| 29 | Gingivitis (HP:0000230) | 3.57543606 |
| 30 | Hypochromic anemia (HP:0001931) | 3.52543522 |
| 31 | Increased IgE level (HP:0003212) | 3.39381080 |
| 32 | Episodic fever (HP:0001954) | 3.38834710 |
| 33 | Peritonitis (HP:0002586) | 3.38486544 |
| 34 | Chest pain (HP:0100749) | 3.37538924 |
| 35 | Spontaneous hematomas (HP:0007420) | 3.31617537 |
| 36 | Pulmonary infiltrates (HP:0002113) | 3.28702589 |
| 37 | Arterial thrombosis (HP:0004420) | 3.21344255 |
| 38 | T lymphocytopenia (HP:0005403) | 3.19456410 |
| 39 | Abnormality of T cell number (HP:0011839) | 3.18822120 |
| 40 | Anorexia (HP:0002039) | 3.18114073 |
| 41 | Leukocytosis (HP:0001974) | 3.10446811 |
| 42 | Prolonged bleeding time (HP:0003010) | 2.99641526 |
| 43 | Increased IgM level (HP:0003496) | 2.92140809 |
| 44 | Gingival bleeding (HP:0000225) | 2.91391826 |
| 45 | Amyloidosis (HP:0011034) | 2.88421189 |
| 46 | Recurrent viral infections (HP:0004429) | 2.86639824 |
| 47 | Gangrene (HP:0100758) | 2.84919859 |
| 48 | Pulmonary embolism (HP:0002204) | 2.82285876 |
| 49 | Cellulitis (HP:0100658) | 2.72558656 |
| 50 | Abnormality of T cells (HP:0002843) | 2.69073075 |
| 51 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.69046986 |
| 52 | Pustule (HP:0200039) | 2.64998375 |
| 53 | Abnormality of the pleura (HP:0002103) | 2.64447036 |
| 54 | Chronic otitis media (HP:0000389) | 2.51924761 |
| 55 | Inflammation of the large intestine (HP:0002037) | 2.51243168 |
| 56 | Abnormality of the endocardium (HP:0004306) | 2.49728729 |
| 57 | Microcytic anemia (HP:0001935) | 2.49033629 |
| 58 | Epistaxis (HP:0000421) | 2.45714887 |
| 59 | Granulocytopenia (HP:0001913) | 2.42999059 |
| 60 | Panhypogammaglobulinemia (HP:0003139) | 2.42409589 |
| 61 | Abnormality of the peritoneum (HP:0002585) | 2.38544178 |
| 62 | Hypergammaglobulinemia (HP:0010702) | 2.37034072 |
| 63 | Gastrointestinal inflammation (HP:0004386) | 2.36699416 |
| 64 | Keratitis (HP:0000491) | 2.35923924 |
| 65 | Osteomyelitis (HP:0002754) | 2.35238792 |
| 66 | Cheilitis (HP:0100825) | 2.33865491 |
| 67 | Petechiae (HP:0000967) | 2.31278540 |
| 68 | Vertigo (HP:0002321) | 2.30832356 |
| 69 | Abnormality of T cell physiology (HP:0011840) | 2.27066198 |
| 70 | Sepsis (HP:0100806) | 2.26835681 |
| 71 | Eosinophilia (HP:0001880) | 2.24851883 |
| 72 | Abnormality of the pericardium (HP:0001697) | 2.24596974 |
| 73 | Glomerulopathy (HP:0100820) | 2.18519249 |
| 74 | Acne (HP:0001061) | 2.16125104 |
| 75 | Premature loss of primary teeth (HP:0006323) | 2.14972189 |
| 76 | Acute hepatic failure (HP:0006554) | 2.11831032 |
| 77 | Stomach cancer (HP:0012126) | 2.07939087 |
| 78 | Lymphopenia (HP:0001888) | 2.07207775 |
| 79 | Polyneuropathy (HP:0001271) | 2.05247627 |
| 80 | Skin ulcer (HP:0200042) | 2.03156206 |
| 81 | Recurrent bronchitis (HP:0002837) | 2.03074698 |
| 82 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.98883747 |
| 83 | Recurrent pneumonia (HP:0006532) | 1.97972055 |
| 84 | Abnormality of iron homeostasis (HP:0011031) | 1.96930062 |
| 85 | Increased serum ferritin (HP:0003281) | 1.95934312 |
| 86 | Abnormality of eosinophils (HP:0001879) | 1.94112744 |
| 87 | Skin rash (HP:0000988) | 1.93354223 |
| 88 | Colitis (HP:0002583) | 1.92202451 |
| 89 | Autoimmune hemolytic anemia (HP:0001890) | 1.91839177 |
| 90 | Amaurosis fugax (HP:0100576) | 1.88434510 |
| 91 | Thrombophlebitis (HP:0004418) | 1.84602891 |
| 92 | Nasal polyposis (HP:0100582) | 1.84175110 |
| 93 | Loss of speech (HP:0002371) | 1.82611543 |
| 94 | Autoimmune thrombocytopenia (HP:0001973) | 1.81925710 |
| 95 | Slow saccadic eye movements (HP:0000514) | 1.79186524 |
| 96 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.78073823 |
| 97 | Purpura (HP:0000979) | 1.77674438 |
| 98 | Viral hepatitis (HP:0006562) | 1.74545139 |
| 99 | Joint swelling (HP:0001386) | 1.74335419 |
| 100 | Arthralgia (HP:0002829) | 1.72633379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.80178924 |
| 2 | IRAK4 | 3.62645581 |
| 3 | TYK2 | 3.49272048 |
| 4 | MAP4K1 | 3.42833920 |
| 5 | BLK | 3.28091862 |
| 6 | CSK | 2.79177511 |
| 7 | MAP2K3 | 2.72529921 |
| 8 | TNK2 | 2.35731830 |
| 9 | JAK3 | 2.34357070 |
| 10 | TXK | 2.28352410 |
| 11 | IKBKE | 2.28241255 |
| 12 | FES | 2.27557316 |
| 13 | ERN1 | 2.19046601 |
| 14 | EPHB1 | 2.13324182 |
| 15 | GRK6 | 2.07094370 |
| 16 | ZAP70 | 2.02098021 |
| 17 | FGR | 2.00492292 |
| 18 | BTK | 1.74837695 |
| 19 | JAK1 | 1.74767653 |
| 20 | HCK | 1.73070870 |
| 21 | MAP3K14 | 1.71092531 |
| 22 | SYK | 1.68214182 |
| 23 | TAOK1 | 1.65867053 |
| 24 | TAOK3 | 1.61995544 |
| 25 | JAK2 | 1.58832617 |
| 26 | MAP3K3 | 1.58795749 |
| 27 | KIT | 1.58271511 |
| 28 | TBK1 | 1.53868345 |
| 29 | MAP3K11 | 1.51434856 |
| 30 | LYN | 1.46269548 |
| 31 | PRPF4B | 1.41296551 |
| 32 | MATK | 1.40069351 |
| 33 | IRAK1 | 1.38170264 |
| 34 | MAP3K13 | 1.27251622 |
| 35 | FGFR4 | 1.20594535 |
| 36 | LCK | 1.18923706 |
| 37 | MAP3K1 | 1.17406348 |
| 38 | YES1 | 1.15056658 |
| 39 | SIK3 | 1.13996746 |
| 40 | KSR2 | 1.12814975 |
| 41 | BMPR2 | 1.07138608 |
| 42 | ITK | 1.05276252 |
| 43 | IKBKB | 1.04421940 |
| 44 | MARK3 | 1.04070608 |
| 45 | GRK7 | 1.03703246 |
| 46 | CSF1R | 1.01590251 |
| 47 | FGFR3 | 0.99404823 |
| 48 | IRAK2 | 0.98884387 |
| 49 | DAPK2 | 0.97112897 |
| 50 | TEC | 0.89928332 |
| 51 | MARK2 | 0.83901356 |
| 52 | PRKD2 | 0.81535113 |
| 53 | SIK2 | 0.78125412 |
| 54 | PTK2B | 0.77460993 |
| 55 | PTK6 | 0.77411986 |
| 56 | PDK1 | 0.77351575 |
| 57 | EPHA3 | 0.75239207 |
| 58 | ACVR1B | 0.73238740 |
| 59 | MAP3K6 | 0.71513707 |
| 60 | CDK19 | 0.70639869 |
| 61 | STK10 | 0.65955013 |
| 62 | MAP3K7 | 0.64534508 |
| 63 | TAOK2 | 0.64411980 |
| 64 | PDPK1 | 0.62888498 |
| 65 | PIK3CG | 0.61706203 |
| 66 | FYN | 0.61102536 |
| 67 | STK11 | 0.59203859 |
| 68 | MAP2K4 | 0.58427334 |
| 69 | MAP2K6 | 0.57793829 |
| 70 | CDC42BPA | 0.57167197 |
| 71 | MAP3K2 | 0.56439695 |
| 72 | MAP3K5 | 0.55593467 |
| 73 | LRRK2 | 0.55210585 |
| 74 | NLK | 0.54833376 |
| 75 | PRKCQ | 0.52749669 |
| 76 | DYRK1B | 0.50933155 |
| 77 | HIPK2 | 0.50910813 |
| 78 | IRAK3 | 0.49645801 |
| 79 | PIM1 | 0.46433529 |
| 80 | TESK2 | 0.45833850 |
| 81 | MAPK12 | 0.44603572 |
| 82 | KSR1 | 0.44521850 |
| 83 | TGFBR2 | 0.44179716 |
| 84 | SGK3 | 0.43141030 |
| 85 | MAPK7 | 0.43128092 |
| 86 | CAMKK2 | 0.39489847 |
| 87 | ADRBK2 | 0.39388493 |
| 88 | STK38 | 0.38438039 |
| 89 | SGK2 | 0.38313268 |
| 90 | RAF1 | 0.38031394 |
| 91 | CAMKK1 | 0.37555339 |
| 92 | PRKCZ | 0.35445734 |
| 93 | DYRK3 | 0.34952299 |
| 94 | WNK1 | 0.33930419 |
| 95 | RPS6KA6 | 0.33713396 |
| 96 | RPS6KC1 | 0.30767089 |
| 97 | RPS6KL1 | 0.30767089 |
| 98 | PRKCD | 0.29878196 |
| 99 | MAPKAPK2 | 0.28027245 |
| 100 | RET | 0.27386722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.17429031 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.08295983 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.02418503 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.63184940 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.62330952 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.51323490 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.42927908 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.30707282 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.27329470 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.24417115 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.15691644 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.11133266 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.01084330 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.00767203 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.98200946 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.96550552 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.90837483 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.90767375 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 1.87430256 |
| 20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.85658389 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.81079190 |
| 22 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.72622192 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.69805568 |
| 24 | Legionellosis_Homo sapiens_hsa05134 | 1.69099242 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.61182216 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.59133288 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57744434 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.57204704 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.56509059 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.52228324 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49783350 |
| 32 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.46720918 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45413624 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 1.44971903 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.39466967 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.38360083 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.37763002 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36462813 |
| 39 | Hepatitis C_Homo sapiens_hsa05160 | 1.32072779 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.23376520 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21235304 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.17936219 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17908508 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.17284307 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01197787 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 0.97639205 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93766651 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 0.92759867 |
| 49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.88529308 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 0.88299431 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86601195 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85922080 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.85906795 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84638291 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78250682 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77036536 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74947299 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.74066157 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68716126 |
| 60 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.68212345 |
| 61 | Endocytosis_Homo sapiens_hsa04144 | 0.62733454 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62308929 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62271183 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 0.61266553 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60945855 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60534874 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60370062 |
| 68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60209191 |
| 69 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59973984 |
| 70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58753808 |
| 71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58169964 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57795037 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55884136 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53435437 |
| 75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52921190 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50382914 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49463242 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.47109946 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44169983 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42904308 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41533987 |
| 82 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39970546 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39713199 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39419400 |
| 85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37640425 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37419502 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36326685 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35547411 |
| 89 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34689365 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.34635785 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34522659 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33366563 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32595604 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31946648 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.24608789 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24488703 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24483962 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.22251814 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21655353 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.21646698 |

